Active, Not Recruiting
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System
NCT05211336
- Conditions
- Aggressive B-cell Lymphoma With Secondary Involvement of the CNS, Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States